Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 58, Number 4, February 26, 2002
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scacheri, P. C.
Right arrow Articles by Hoffman, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scacheri, P. C.
Right arrow Articles by Hoffman, E. P.
Related Collections
Right arrow All Neuro-ophthalmology
Right arrow All epidemiology
Right arrow Genetic linkage
Neurology 2002;58:593-602
© 2002 American Academy of Neurology

Novel mutations in collagen VI genes

Expansion of the Bethlem myopathy phenotype

P. C. Scacheri, PhD;, E. M. Gillanders, MS;, S. H. Subramony, MD;, V. Vedanarayanan, MD;, C. A. Crowe, MD;, N. Thakore, MD;, M. Bingler, BS; and E. P. Hoffman, PhD

From the Department of Molecular Genetics and Biochemistry (Drs. Scacheri and Hoffman, and M. Bingler), University of Pittsburgh School of Medicine, Pittsburgh, PA; Research Center for Genetic Medicine (Drs. Scacheri and Hoffman), Children’s National Medical Center, George Washington University, Washington, DC; Cancer Genetics Branch (Dr. Thakore and E.M. Gillanders), National Human Genome Research Institute, Bethesda, MD; Department of Neurology (Drs. Subramony and Vedanarayanan), University of Mississippi Medical Center, Jackson, MS; and Division of Genetics (Dr. Crowe), MetroHealth Medical Center, Cleveland, OH.

Address correspondence and reprint requests to Dr. Eric P. Hoffman, Research Center for Genetic Medicine, Children’s National Medical Center, 111 Michigan Ave. NW, Washington, DC 20010; e-mail: ehoffman{at}cnmc.org

Objective: To investigate the molecular basis of autosomal dominant limb-girdle muscular dystrophy (AD-LGMD) in three large new families.

Methods andResults: Genome-wide linkage was performed to show that the causative gene in all three families localized to chromosome 21q22.3 (Zmax = 10.3; {theta} = 0). This region contained the collagen VI {alpha}1 and {alpha}2 genes, which have been previously shown to harbor mutations causing a relatively mild congenital myopathy with contractures (Bethlem myopathy). Screening of the collagen VI {alpha}1 and {alpha}2 genes revealed novel, causative mutations in each family (COL6A1—K121R, G341D; COL6A2—D620N); two of these mutations were in novel regions of the proteins not previously associated with disease. Collagen VI is a ubiquitously expressed component of connective tissue; however, both limb-girdle muscular dystrophy and Bethlem myopathy patients show symptoms restricted to skeletal muscle. To address the muscle-specific symptoms resulting from collagen VI mutations, the authors studied three patient muscle biopsies at the molecular level (protein expression). A marked reduction of laminin ß1 protein in the myofiber basal lamina in all biopsies was found, although this protein was expressed normally in the neighboring capillary basal laminae.

Conclusions: The authors’ studies widen the clinical spectrum of Bethlem myopathy and suggest collagen VI etiology should be investigated in dominant limb-girdle muscular dystrophy. The authors hypothesize that collagen VI mutations lead to muscle-specific defects of the basal lamina, and may explain the muscle-specific symptoms of Bethlem and limb-girdle muscular dystrophy patients with collagen VI mutations.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. R. Lamande, M. Morgelin, N. E. Adams, C. Selan, and J. M. Allen
The C5 Domain of the Collagen VI {alpha}3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells
J. Biol. Chem., June 16, 2006; 281(24): 16607 - 16614.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A K Lampe and K M D Bushby
Collagen VI related muscle disorders
J. Med. Genet., September 1, 2005; 42(9): 673 - 685.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Lucioli, B. Giusti, E. Mercuri, O. C. Vanegas, L. Lucarini, V. Pietroni, A. Urtizberea, R. B. Yaou, M. de Visser, A. J. van der Kooi, et al.
Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy
Neurology, June 14, 2005; 64(11): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A K Lampe, D M Dunn, A C von Niederhausern, C Hamil, A Aoyagi, S H Laval, S K Marie, M-L Chu, K Swoboda, F Muntoni, et al.
Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy
J. Med. Genet., February 1, 2005; 42(2): 108 - 120.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. L. Baker, M. Morgelin, R. Peat, N. Goemans, K. N. North, J. F. Bateman, and S. R. Lamande
Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy
Hum. Mol. Genet., January 15, 2005; 14(2): 279 - 293.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Kirschner and C. G. Bonnemann
The Congenital and Limb-Girdle Muscular Dystrophies: Sharpening the Focus, Blurring the Boundaries
Arch Neurol, February 1, 2004; 61(2): 189 - 199.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R.-Z. Zhang, P. Sabatelli, T.-C. Pan, S. Squarzoni, E. Mattioli, E. Bertini, G. Pepe, and M.-L. Chu
Effects on Collagen VI mRNA Stability and Microfibrillar Assembly of Three COL6A2 Mutations in Two Families with Ullrich Congenital Muscular Dystrophy
J. Biol. Chem., November 8, 2002; 277(46): 43557 - 43564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.